Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Pichard

Showing results (141-150 of 158) with videos related to

Pageof 16
Sort By:
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|January 7, 2026
CURE ID: A Platform to Collect Real-World Treatment Data for Drug Repurposing in Rare Genetic DisordersTahsin Farid, Maura R Z Ruzhnikov, Mili Duggal, et al.
Neurology|July 7, 2021
Perspective of Adults With Neurofibromatosis 1 and Cutaneous Neurofibromas: Implications for Clinical TrialsAshley Cannon, Dominique C Pichard, Pamela L Wolters, et al.
Clinical Trials (London, England)|June 3, 2023
Perspectives of adolescents with neurofibromatosis 1 and cutaneous neurofibromas: Implications for clinical trialsAshley Cannon, Kavita Y Sarin, Andrea K Petersen, et al.
Clinical Nutrition (Edinburgh, Scotland)|June 20, 2008
Nutrition in care homes and home care: how to implement adequate strategies (report of the Brussels Forum (22-23 November 2007))M Arvanitakis, A Beck, P Coppens, et al.
Clinical Nutrition (Edinburgh, Scotland)|July 4, 2009
Decreased food intake is a risk factor for mortality in hospitalised patients: the NutritionDay survey 2006M Hiesmayr, K Schindler, E Pernicka, et al.
JAMA Dermatology|February 26, 2025
Treatment of Cutaneous Neurofibromas in Neurofibromatosis Type 1 With MEK Inhibitor Selumetinib: A Nonrandomized Clinical TrialAndrea M Gross, Olivia H Reid, Lauren A Baldwin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 12, 2017
Predictors for Permanent Discontinuation of Systemic Immunosuppression in Severely Affected Chronic Graft-Versus-Host Disease PatientsLauren M Curtis, Filip Pirsl, Seth M Steinberg, et al.
Genetic Analysis : Biomolecular Engineering|December 22, 1999
From the molecular biology of prolactin and its receptor to the lessons learned from knockout mice modelsV Goffin, N Binart, P Clément-Lacroix, et al.
Frontiers in Immunology|September 13, 2024
Human papillomavirus disease in <i>GATA2</i> deficiency: a genetic predisposition to HPV-associated female anogenital malignancyEhren Dancy, Pamela Stratton, Dominique C Pichard, et al.
Clinical Trials (London, England)|October 25, 2023
Development and pilot validation of a novel disfigurement severity scale for plexiform neurofibromas in children with neurofibromatosis type 1Liny John, Gurbani Singh, Eva Dombi, et al.
Pageof 16

Showing results (141-150 of 158) with videos related to

Sort By:
Pageof 16
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|January 7, 2026
CURE ID: A Platform to Collect Real-World Treatment Data for Drug Repurposing in Rare Genetic DisordersTahsin Farid, Maura R Z Ruzhnikov, Mili Duggal, et al.
Neurology|July 7, 2021
Perspective of Adults With Neurofibromatosis 1 and Cutaneous Neurofibromas: Implications for Clinical TrialsAshley Cannon, Dominique C Pichard, Pamela L Wolters, et al.
Clinical Trials (London, England)|June 3, 2023
Perspectives of adolescents with neurofibromatosis 1 and cutaneous neurofibromas: Implications for clinical trialsAshley Cannon, Kavita Y Sarin, Andrea K Petersen, et al.
Clinical Nutrition (Edinburgh, Scotland)|June 20, 2008
Nutrition in care homes and home care: how to implement adequate strategies (report of the Brussels Forum (22-23 November 2007))M Arvanitakis, A Beck, P Coppens, et al.
Clinical Nutrition (Edinburgh, Scotland)|July 4, 2009
Decreased food intake is a risk factor for mortality in hospitalised patients: the NutritionDay survey 2006M Hiesmayr, K Schindler, E Pernicka, et al.
JAMA Dermatology|February 26, 2025
Treatment of Cutaneous Neurofibromas in Neurofibromatosis Type 1 With MEK Inhibitor Selumetinib: A Nonrandomized Clinical TrialAndrea M Gross, Olivia H Reid, Lauren A Baldwin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 12, 2017
Predictors for Permanent Discontinuation of Systemic Immunosuppression in Severely Affected Chronic Graft-Versus-Host Disease PatientsLauren M Curtis, Filip Pirsl, Seth M Steinberg, et al.
Genetic Analysis : Biomolecular Engineering|December 22, 1999
From the molecular biology of prolactin and its receptor to the lessons learned from knockout mice modelsV Goffin, N Binart, P Clément-Lacroix, et al.
Frontiers in Immunology|September 13, 2024
Human papillomavirus disease in <i>GATA2</i> deficiency: a genetic predisposition to HPV-associated female anogenital malignancyEhren Dancy, Pamela Stratton, Dominique C Pichard, et al.
Clinical Trials (London, England)|October 25, 2023
Development and pilot validation of a novel disfigurement severity scale for plexiform neurofibromas in children with neurofibromatosis type 1Liny John, Gurbani Singh, Eva Dombi, et al.
Pageof 16